Related references
Note: Only part of the references are listed.Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas
Carole Colin et al.
ACTA NEUROPATHOLOGICA (2009)
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
O. Martinho et al.
BRITISH JOURNAL OF CANCER (2009)
A microarray-based DNA methylation study of glioblastoma multiforme
Ramon Martinez et al.
EPIGENETICS (2009)
TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness
Eric Chastre et al.
FASEB JOURNAL (2009)
Aberrant DNA Methylation Profile and Frequent Methylation of KLK10 and OXGR1 Genes in Hepatocellular Carcinoma
Chang-Yi Lu et al.
GENES CHROMOSOMES & CANCER (2009)
Epigenetic Control of the Invasion-promoting MT1-MMP/MMP-2/TIMP-2 Axis in Cancer Cells
Andrei V. Chernov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms
Jose I. Martin-Subero et al.
PLOS ONE (2009)
Aberrant promoter methylation and expression of the imprinted PEG3 gene in glioma
Susumu Otsuka et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development
Hao Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Tumor Necrosis Factor-Alpha and Its Receptors Contribute to Apoptosis of Oligodendrocytes in the Spinal Cord of Spinal Hyperostotic Mouse (twy/twy) Sustaining Chronic Mechanical Compression
Tomoo Inukai et al.
SPINE (2009)
Considerations for the processing and analysis of GoldenGate-based two-colour Illumina platforms
A. G. Lynch et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2009)
Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss
Markus J. Riemenschneider et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
Francois Ducray et al.
MOLECULAR CANCER (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas
Ahmed Idbaih et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Decreased CHK protein levels are associated with Src activation in colon cancer cells
S. Zhu et al.
ONCOGENE (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma
John K. Wiencke et al.
NEURO-ONCOLOGY (2007)
CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme
Ramon Martinez et al.
CARCINOGENESIS (2007)
Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression
Tetsuo Kondo et al.
CANCER RESEARCH (2007)
Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells
Xuegong Zhu et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme
Ramon Martinez et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation
Benoit Cadieux et al.
CANCER RESEARCH (2006)
Highly parallel genomic assays
Jian-Bing Fan et al.
NATURE REVIEWS GENETICS (2006)
Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors
M Ehrlich et al.
ONCOGENE (2006)
High-throughput DNA methylation profiling using universal bead arrays
M Bibikova et al.
GENOME RESEARCH (2006)
Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2
R Ram et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Microarray analysis of promoter methylation in lung cancers
M Fukasawa et al.
JOURNAL OF HUMAN GENETICS (2006)
TP53 promoter methylation in human gliomas
VJ Amatya et al.
ACTA NEUROPATHOLOGICA (2005)
Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer
MD Bashyam et al.
NEOPLASIA (2005)
A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma
JC Strefford et al.
CANCER GENETICS AND CYTOGENETICS (2005)
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma
M Alaminos et al.
CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Epigenetic silencing of the protocadherin family member PCDH-γ-A11 in astrocytomas
A Waha et al.
NEOPLASIA (2005)
Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors
M Möllemann et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas
L Hesson et al.
ONCOGENE (2004)
Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma
J Yu et al.
BMC CANCER (2004)
Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing
Y Tokumaru et al.
CANCER RESEARCH (2004)
Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors
SO Kim et al.
CANCER (2004)
Allelic imbalance mapped to 6q14.1 is associated with loss of expression of 5-HT receptor 1B in non-Hodgkin lymphomas
CYS Li et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2004)
A critical role of neural-specific JNK3 for ischemic apoptosis
CY Kuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
PTEN methylation and expression in glioblastomas
N Baeza et al.
ACTA NEUROPATHOLOGICA (2003)
Automatic registration of microarray images. II. Hexagonal grid
VL Galinsky
BIOINFORMATICS (2003)
Proteases in brain tumour progression
N Levicar et al.
ACTA NEUROCHIRURGICA (2003)
Distinct methylation profiles of glioma subtypes
K Uhlmann et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis
D Takai et al.
ONCOGENE (2001)
MethyLight: a high-throughput assay to measure DNA methylation
Cindy A. Eads et al.
NUCLEIC ACIDS RESEARCH (2000)